Lonaka Harbor, NJ, United States of America

Bret C Vastano

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bret C Vastano. Retrieved from https://idiyas.com/inventor/bret-c-vastano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bret C Vastano: Innovator in Anticarcinogenic Research

Introduction

Bret C Vastano is a notable inventor based in Lonaka Harbor, NJ (US). He has made significant contributions to the field of cancer research through his innovative work. His dedication to developing effective treatments showcases his commitment to improving health outcomes.

Latest Patents

Vastano holds a patent for the "Use of 1-propanone-1-(2,4-dihydroxyphenyl)-3-hydroxy-3-(4′-hydroxyphenyl) as an anticarcinogenic agent." This patent outlines compositions and methods aimed at the prevention and treatment of cancer. The compositions include pure hydroxylated chalcone compounds derived from licorice root, specifically highlighting the compound 1-propanone-1-(2,4-dihydroxyphenyl)-3-hydroxy-3-(4′-hydroxyphenyl). He has 1 patent to his name.

Career Highlights

Throughout his career, Vastano has focused on innovative solutions in the medical field. His research has the potential to impact cancer treatment significantly. His work exemplifies the intersection of science and practical application in healthcare.

Collaborations

Vastano has collaborated with esteemed colleagues, including Robert T Rosen and Robert S Dipaola. These partnerships have likely enhanced the scope and impact of his research endeavors.

Conclusion

Bret C Vastano's contributions to anticarcinogenic research highlight his role as an influential inventor. His innovative patent reflects a commitment to advancing cancer treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…